Document is current

Any future updates will be listed below

3 mg Sumatriptan s. c. erweitert Optionen für individualisierte Migränetherapie

Crossref DOI link: https://doi.org/10.1007/s00940-021-3093-6

Published Online: 2021-05-28

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark